RCM Technologies (RCMT) Q4 2024 earnings summary

Executive summary

• Strong top-line momentum in Q4 2024, with revenue rising 8.3% year-over-year to $76.9M; full-year revenue up 5.8% to $278.4M, but profitability was impacted by discrete, non-recurring items not indicative of ongoing earnings power.

• Q4 GAAP net income was $2.9M ($0.37/diluted share), down from $5.3M ($0.65) in Q4 2023; full-year net income was $13.3M ($1.68), down from $16.8M ($1.96).

• Adjusted EBITDA for Q4 2024 was $6.3M, down from $8.9M in Q4 2023; fiscal 2024 adjusted EBITDA was $25.9M, slightly below $26.6M in 2023.

• Adjusted EPS for fiscal 2024 was $2.03, nearly flat versus $2.04 in 2023.

• Entering 2025 with optimism, supported by a robust pipeline, deepening client relationships, and expansion in core markets.

Financial highlights

• Consolidated gross profit for Q4 2024 was $21.6M, flat year-over-year; fiscal 2024 gross profit was $79.8M, up 4.0% from $76.7M in 2023.

• Q4 operating income was $6.3M (down from $7.9M); full-year operating income was $22.3M (down from $23.7M).

• Cash and cash equivalents at year-end were $4.7M, down from $6.3M; total assets increased to $132.1M from $120.5M.

• Net cash provided by operating activities for the year was $6.2M, down from $12.5M in 2023.

• Q4 2024 results were negatively impacted by a $900K reduction in gross profit from a canceled industrial order and project rework, and $1.25M in abnormally high medical costs.

Outlook and guidance

• Targeting at least double-digit adjusted EBITDA growth for all quarters in fiscal 2025.

• Optimism for 2025 driven by strong pipelines, new contracts, and market expansion.

• Expectation for effective tax rate to normalize below 30% in 2025, with a typical range of 26–29%.

• Management anticipates a foundation for increased earnings power in 2025, citing traction in strategic initiatives.